中國疾控中心王華慶:有花粉過敏史不是接種新冠病毒疫苗的禁忌
格隆匯4月6日丨中國疾控中心免疫規劃首席專家王華慶今日在國務院聯防聯控機制新聞發佈會上表示,春季是花粉過敏的高峯期,有花粉過敏史不是接種新冠病毒疫苗的禁忌。只有接種新冠病毒疫苗過敏的或對新冠病毒疫苗中成分過敏或既往接種其他疫苗發生嚴重過敏的,纔是接種新冠病毒疫苗的禁忌。如果花粉過敏者正在過敏的急性發作期,特別是花粉過敏導致哮喘等嚴重症狀發作的,要緩種疫苗。對有花粉過敏史可以接種疫苗的,接種疫苗時,要告知臨牀醫生或接種醫生,也要嚴格遵守接種後留觀三十分鐘的規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.